Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. One Way Drug, LLC
WARNING LETTER
•One Way Drug, LLC•May 30, 2014

One Way Drug, LLC – FDA Warning Letter, May 30, 2014

Record Details

This FDA Warning Letter, dated July 22, 2015, was issued to One Way Drug, LLC dba Partell Specialty Pharmacy following an inspection from May 21-30, 2014. The inspection revealed serious deficiencies in sterile drug product production and non-compliance with federal regulations.

Key violations include: - **Lack of Valid Prescriptions:** The firm produced drug products without valid prescriptions for individually-identified patients, violating Section 503A of the FDCA, rendering these drugs unapproved new drugs and misbranded. - **Insanitary Conditions & Adulteration:** Sterile drug products were prepared under insanitary conditions, leading to adulteration under Section 501(a)(2)(A) of the FDCA. Specific observations included: - Operators stoppering vials with gloved hands on a partially separated table and processing sterile products with exposed skin. - Failure to use sporicidal agents for cleaning production areas. - Infrequent viable and non-viable monitoring. - Lack of continuous pressure differential monitoring. - Transfer of bulk drug product containers into ISO-5 area without sanitization. - Failure to demonstrate adequate protection of the ISO-5 area by the workbench. - **CGMP Violations:** Significant Current Good Manufacturing Practice (CGMP) violations were observed, causing drugs to be adulterated under Section 501(a)(2

Company
One Way Drug, LLC
Inspection date
May 30, 2014
Product type
Drugs
Office
San Francisco District Office
People
  • Kathleen M. Lewis
  • Larry L. Pinson (Executive Secretary)
View Company Profile

ID · f6184a30-d9ce-43ec-9a80-0a2f8160df6b

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 353a21 U.S.C. 352(f)(1)21 U.S.C. 35521 U.S.C. 331(d)21 U.S.C. 331(k)21 U.S.C. 351(a)(2)(A)21 CFR 211.113(b)21 CFR 211.42(c)(10)(iv)

Full citation text and observation details available on the Dashboard.

Other documents for One Way Drug, LLC
  • 483 - 2017-07-19July 19, 2017
  • 483 - 2014-05-30May 30, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore One Way Drug, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.